CBV is a vital perfusion parameter in estimating the viability of brain parenchyma (eg, in cases of ischemic stroke or after interventional vessel occlusion). Recent technologic advances allow parenchymal CBV imaging tableside in the angiography suite just before, during, or after an interventional procedure. The aim of this work was to analyze our preliminary clinical experience with this new imaging tool in different neurovascular interventions.
T oday, FPD-mounted C-arm angiographic systems have been widely introduced into neurointerventional suites. FPD imaging techniques not only allow the acquisition of high-quality 3D vascular imaging (3D rotational angiography) but also obtain CT-like cross-sectional soft-tissue imaging (FPD-CT). Applications include assessment of the extent of SAH or intracerebral hemorrhage and the width of the ventricles, [1] [2] [3] [4] and immediate evaluation of coil and stent placement in the treatment of intracranial aneurysms. 5, 6 FPD-CT has also been shown to be capable of visualizing the struts of a stent during intracranial placement [6] [7] [8] and extracranial carotid artery stent placement. 9 FPD technology allows fast imaging without the need for time-consuming transfer to a CT facility and, therefore, has become a helpful tool for immediate, "on the table" evaluation of treatment results and intraprocedural complications.
CBV is an important parameter for assessing the viability of brain tissue. A significant drop of CBV in the clinical setting of acute ischemic stroke signifies failure of local parenchymal compensatory mechanisms and the irreversibility of the ischemic damage. The CBF and the temporal perfusion maps help to delineate the potentially reversible ischemic penumbra. Recently, the possibility of performing whole-brain parenchymal CBV measurements has been added to the spectrum of FPD-CT imaging. Feasibility studies in canines 10, 11 and preliminary clinical studies 12, 13 have shown that CBV mapping by using FPD-CT after intravenous contrast media injection is feasible, safe, and capable of depicting CBV values comparable with standard multisection CT perfusion. Furthermore, FPD-CBV imaging offers the advantage of whole-brain coverage not always available by conventional CT perfusion measurements.
However, despite the current limitation in temporal resolution being unable to provide additional dynamic perfusion maps like CBF or TTP measurements, tableside FPD-CBV may offer a further adjunctive on-line tool to evaluate and monitor cerebral perfusion as a physiologic parameter to guide treatment decisions and to evaluate treatment effect. Particularly, patients undergoing revascularization procedures for acute or chronic stroke may benefit from advanced image-guided management. Only a few clinical data on the impact on clinical decision-making and peri-interventional monitoring of neurovascular procedures by using FPD-CBV have been published so far, to our knowledge.
The purpose of this study was to review our preliminary clinical experience evaluating the applicability and usability of tableside peri-interventional FPD-CBV mapping as an additional imaging tool in different neurovascular interventions.
Materials and Methods

Patient Characteristics
Between August and November 2010, 18 patients (11 women, 7 men; age range, 18 -86 years; median, 58.7 years) with different cerebrovascular pathologies referred for cerebral angiography were examined. This Health Insurance Portability and Accountability Actcompliant study was performed according to the guidelines of our institution, and informed consent was waived. Presenting symptoms included acute stroke or stroke-like symptoms in 6 patients, subacute stroke in 4 patients, headache and nausea in 6 patients, and impairment/loss of consciousness in 2 patients. In the 10 patients with stroke, the causative arterial stenosis or occlusion was confirmed. The remaining 8 patients had an intracranial hemorrhage, 3 had an SAH due to aneurysmal rupture and 1, due to a posttraumatic dissecting aneurysm. The FPD-CBV acquisitions were performed in these cases to exclude hypoperfusion complicating the endovascular intervention (eg, stent placement, coiling, and/or embolization). Patient clinical data and characteristics are summarized in the Table. FPD-CBV Measurement FPD-CBV measurement was performed on a biplane FPD angiographic system (Axiom Artis Zee; Siemens, Erlangen, Germany). As previously described, 12,13 data acquisition consisted of 2 rotations: an initial mask run followed by a second fill run. Data acquisition was performed by using the following imaging parameters: acquisition time, 8 seconds; 70 kV; 616 ϫ 480 matrix; projection on a 30 ϫ 40 cm flat panel size; 200°t otal angle, 0.5°/frame; 400 frames total; dose, 1.20 Gy/frame. To obtain the necessary steady-state contrast medium opacification of the brain parenchyma for CBV data acquisition during the fill run, the technique of "bolus watching" was applied as previously described. 12, 13 In brief, contrast medium injection was started simultaneously with the mask run. After return of the C-arm to the starting position, conventional DSA acquisitions at a rate of 1 image per second were obtained until opacification of the transverse sinus was seen by the interventionalist as a surrogate marker for steady-state parenchymal contrast medium filling. At this point, the fill run for CBV data acquisition was manually started. Intravenous and intra-arterial injection protocols according to the interventionalist's discretion were used. Contrast media injections were performed by using 50 mL of iodinated contrast material (iopamidol, Iopamiro 300; Bracco, Milan, Italy) either through a peripheral cubital venous access (20-ga) in 15 patients or intra-arterially in 3 patients through a pigtail catheter (6F, Torcon NB Advantage Catheter; Cook, Bloomington, Indiana) placed in the ascending aorta at a rate of 5 mL/s by using a power injector (Angiomat Illumena; LiebelFlarsheim, Cincinnati, Ohio). However, during the study, the route of pre-and postprocedural contrast application was consistent in all cases, allowing a comparison of datasets within the case. The details of the injection protocol for each patient are described in the Table.
Patient clinical data and characteristics
Postprocessing of FPD-CBV Data
Postprocessing of FPD-CBV data was performed by using commercially available imaging software (syngo Neuro PBV IR; Siemens) installed on the imaging workstation (Leonardo; Siemens). Multiplanar reconstructions (section thickness, 5 mm) were performed covering the whole-brain parenchyma in axial, coronal, and sagittal planes. CBV images were stored on a workstation for analysis. Images were visually assessed together by 2 neuroradiologists (P.M., M.E.-K.) in consensus, unaware of patient histories and pathology for asymmetry in parenchymal CBV.
Results
In the 18 cases studied, 23 CBV measurements were performed. Twenty acquisitions were of proper diagnostic quality. The remaining 3 acquisitions had technical failure (1 due to motion artifacts, 2 due to injection technique and/or hardware failure). The technical failures decreased as further patients were examined, probably representing a learning-curve effect.
Illustrative Cases
Case 1. A 53-year-old patient (patient 1) was referred for stroke with acute right hemiparesis and aphasia, 3.5 hours after the onset of symptoms. The National Institutes of Health Stroke Scale score at presentation was 19. Emergency MR imaging revealed a diffusion restriction of the left MCA territory and a wide diffusion-perfusion mismatch including the whole left MCA territory and partial ACA territory due to an ICA and M1 occlusion (Fig 1AϪC) . The patient was immediately transferred to the neurointerventional suite for endovascular stroke treatment. Diagnostic DSA confirmed an occlusion of the left ICA from the bifurcation. Preinterventional FPD-CBV by using an intra-arterial injection protocol with a pigtail catheter placed in the descending aorta was performed, showing decrease in CBV values consisting of the whole MCA and parts of the ACA territory (Fig 1D) . TIMI 3 recanalization of the ICA and M1 could be achieved by stent placement in the ICA and intra-arterial thrombolysis by using 1 million IU of urokinase. Immediate postinterventional control FPD-CBV measurement depicted normalization of CBV values in the left MCA and ACA territories with signs of hyperperfusion in the parietal lobe (Fig 1E) . Control MR imaging 4 days after the intervention showed cerebral infarction restricted to the initial area of diffusion restriction in the left MCA territory without diffusion-perfusion mismatch (Fig 1FϪH) .
Case 2. A 47-year-old patient (patient 11) presented to the emergency department with an episode of sudden headache and nausea. CT evaluation showed an SAH and a suspected PICA aneurysm on the right. DSA depicted a partially saccular multilobulated aneurysm of the PICA with fusiform dilation incorporating the adjacent vessel segment (Fig 2A) . Because of its partially fusiform appearance and the extent of the lesion, a dissecting aneurysm was suspected and segment occlusion intended. Pre-and postinterventional FPD-CT was performed to evaluate the extent of the CBV deficit to anticipate the necessity of decompressive craniotomy in this sedated and intubated patient. Vessel sacrifice by embolization of the PICA by using N-butyl-2-cyanoacrylate (Histoacryl) (Tissue Seal, Ann Arbor, Michigan) was performed, and complete vessel occlusion could be achieved (Fig 2B) .
Immediately after the termination of the embolization, an FPD-CBV measurement was performed depicting a CBV decrease in the right PICA territory (Fig 2C) . A control CT scan confirmed the postinterventional PICA infarction (Fig 2D) , and decompressive craniotomy was performed.
Discussion
Imaging techniques for assessment of cerebral perfusion are traditionally indicated in hypoperfusion (eg, arterial occlusions or stenosis) as well as in hyperperfusion states (eg, after carotid stent placement or endarterectomy) and in cases of seizure. In the past 2 decades, CTP and MRP have been introduced as robust and more widely available alternatives to positron-emission tomography and single-photon emission CT. The most commonly used CTP and MRP parameters are CBV, CBF, and temporal parameters including TTP and mean transit time. Furthermore, a recent publication showed that CT angiographic source images correlate more closely with CBF anomalies, whereas postcontrast CT correlates more with CBV defects.
14 A significant drop of CBV in the clinical setting of acute ischemic stroke signifies failure of local parenchymal compensatory mechanisms and the irreversibility of the ischemic damage. The CBF and the temporal perfusion maps help to delineate the potentially reversible ischemic penumbra.
From our experience, FPD-CT has various possible indications in the future for perfusion assessment before and after neurovascular interventions: 1) patients with ischemic stroke and patients with symptomatic and/or high-grade stenosis indicated for an endovascular revascularization procedure, 2) before and after spasmolysis after SAH, 3) intracranial and head and neck tumors before and after embolization (eg, preoperative devascularization of a meningioma or other vascular neoplasms), and 4) after interventional vessel sacrifice (eg, during treatment of dissections) to determine the extent of infarction and to tailor postinterventional monitoring or decompressive surgery.
In such cases, a tableside technique integrated into the neuroangiography suite represents an extremely appealing method for on-line peri-interventional assessment of perfusion. This provides the advantage of rapid on-line decisionmaking and obviates tedious transport to and from an MR imaging or CT scanner.
Furthermore, to our knowledge, few publications on FPD-CT have focused on the imaging of intraprocedural complications, (eg, hemorrhage, vessel rupture, or depiction of the installed endovascular treatment armamentarium, including stents and coils). Perfusion imaging with FPD-CT has been recently introduced to the neuroradiologic arena. The first studies documented results comparable with CBV values acquired by multisection CTP technology.
However, the FPD-CBV technique still has some limitations. In our preliminary experience, a few technical and hardware failures occurred. In 1 case, the motion artifacts significantly degraded the perfusion images. In 2 other cases, a hardware/injector failure was responsible for the low quality of the images. Our suggestions for improving the quality and reproducibility of the technique include the following: 1) a uniform protocol of injection, and 2) intravenous injection protocol. Intra-arterial injection protocols are feasible but need the introduction of a pigtail catheter into the aortic arch, which is time-consuming, especially in acute stroke treatment. On the other hand, intravenous contrast injection seems to be a straightforward and reliable method of contrast administration to achieve reproducible FPD-CBV measurements. Furthermore, this technique currently yields only CBV maps. CBF and temporal maps are not available yet. However, other perfusion techniques have this limitation of providing only 1 perfusion parameter (eg, arterial spin-labeling, which only provides CBF data). CBU maps obtained with FPD-CBV can provide absolute quantification if post-processing on the imaging work station is performed.
Limitations
A limited study of patients with various cerebrovascular pathologies was reported. The injection protocol was not uniform in all cases.
Conclusions
FPD-CBV measurement in the angiography suite provides an attractive and feasible tool for peri-interventional neuroimaging. It extends the periprocedural imaging modalities to the level of tissue perfusion. However, the technique still has some technical limitations and shows room for improvement.
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